Dr. Ankur Bahl is a highly regarded cancer specialist with over 15 years of experience. 

He is an expert in targeted therapies, chemotherapy, hormonal therapy, and immunotherapy. 

Dr. Bahl is the lead author of the largest real-world Indian data on targeted therapy (Cetuximab) for head and neck cancer, the treatment of acute myeloid leukemia, and trends in human papillomavirus (HPV) in the Indian population.

Additionally, he has developed several innovative oncology education platforms, including evidence-based debates in oncology, live tumor boards, master classes, and workshops, helping to shape the future of cancer treatment education.

Dr. Bahl is known for his calm and reassuring presence, ensuring that each patient understands their diagnosis and treatment options. He breaks down even the most complex procedures into simple, easy-to-understand terms, helping patients feel informed, supported, and at ease during their treatment journey.